Navigation Links
TGen findings highlighted at 7th annual cancer conference
Date:3/14/2013

SCOTTSDALE, Ariz. March 14, 2013 The Translational Genomics Research Institute (TGen) will present its latest research about a cancer known as multiple myeloma at a free public conference hosted by the Arizona Myeloma Network (AzMN).

More than 300 people are expected at AzMN's 7th annual "Living with Myeloma" conference, planned from 9 a.m.-4:30 p.m. Saturday, March 23, at the Chaparral Suites Ballroom, 5001 N. Scottsdale Road, Scottsdale, Ariz.

The conference is designed to provide patients, their families, friends, caregivers, researchers, physicians and healthcare professionals with cutting-edge information about the latest research and the newest therapies for myeloma, which is a complex and often misdiagnosed cancer of bone marrow plasma cells, which attack and destroy bone.

TGen's Dr. Bodour Salhia, an Assistant Professor in TGen's Integrated Cancer Genomics Division, will present her research, looking into new approaches for targeting multiple myeloma.

Dr. Salhia's focus is on the affects of epigenetic changes heritable changes in DNA that do not affect an individual's DNA sequence and how those changes might play a role in affecting the function of genes.

"I am thrilled to once again be presenting at AzMN's annual Living with Myeloma conference," Dr. Salhia said. "I will be talking specifically about the focus of research ongoing in my lab that revolves around understanding the epigenetic changes underlying multiple myeloma.

"My hope is to translate these findings into epigenetic therapies for patients, especially in treatment resistant myeloma," Dr. Salhia said. "I think this is a great venue to share some of the latest in this research to the this patient-based audience."

In addition to TGen's Dr. Salhia, other nationally recognized myeloma experts from Arizona and across the nation scheduled for the conference are: Dr. Robert Kyle, Mayo Clinic, Rochester; Dr. Joseph Mikhael, Mayo Clinic, Scottsdale; Dr. Jeffrey Schriber, Bone Marrow Institute, Scottsdale Healthcare's Virginia G. Piper Cancer Center.

"This year, our myeloma conference will focus on collaboration among researchers, clinicians, and patient advocates in creating a roadmap to a cure for myeloma," said Barbara Kavanagh, Founder and President of the Arizona Myeloma Network. "This is a key opportunity for patients and families to learn about this rare form of blood cancer, and other cancers, to feel less alone, and find hope for the future."

Registration is online at http://www.azmyelomanetwork.org/what/2013confreg.html, or from 8-9 a.m. at the conference. Free continental breakfast and lunch will be provided, and 5.75 Continuing Medical Education credits are available to medical professionals.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. AIDS journal publishes findings of 2 important studies in Mar. 2013 issue
2. Independent panel to present findings on diagnosing gestational diabetes mellitus
3. Researchers uncover new findings on genetic risks of Behçets disease
4. Pitt/UPMC team describes findings from BCI study in spinal cord-injured man in PLoS One
5. Study Says Timing of Lunch May Impact Weight Loss – Celebrity Beverly Hills Doctor Discusses the Findings
6. Sovereign Health of California Is Concerned About Recent CDC Findings Highlighting The Health Risk of Alcohol Abuse And Binge Drinking Among Women
7. Researchers uncover genes role in rheumatoid arthritis, findings pave way for new treatments
8. Study findings have potential to prevent,reverse disabilities in children born prematurely
9. New findings on killer bacterias defence
10. Lorna Kleidman Responds to New Findings that Exercise Enhances Memory
11. Findings support safety of whooping cough vaccine for older adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... 2017 , ... The Women’s Choice Award, a growing platform that gives a ... Women’s Choice Award. The identification by women of an effective new migraine relief ... are women. In a survey taken by the Women’s Choice Award organization, nine out ...
(Date:8/22/2017)... ... 2017 , ... Pivot Point Consulting, a ... the firm’s new Consulting Services Executive. Mr. Tisch will oversee all aspects of ... clients with initial vendor selection and pre-implementation planning through go-live support and post-live ...
(Date:8/22/2017)... ... , ... Nurses at Apple Rehab Watch Hill , a nursing and ... certification in Closed Pulse Irrigation™ (CPI) for wound care. This qualifies ... for Medicare and Medicaid Services, to have a CPI machine that will provide better ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... ... “Glimpses Of Light”: is a unique and thought inspiring guide toward self-discovery ... published author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the author has spent ... shares, “Love is one of the least understood and yet most sought-after pleasures known ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... Fenita J. Caldwell is ... Lifetime Professional in the Field of Healthcare. Caldwell ... Pharmaceuticals, AG. Her skills and areas of expertise ... Fenita ... experience as a highly successful sales specialist in ...
(Date:8/2/2017)... 2017  Life Flight Network and PeaceHealth Oregon Network announced ... care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Life Flight Network work collaboratively to move patients who require ... a time sensitive emergency exists. ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: